Learn More
Medchemexpress LLC Cyclopropylboronic acid | 411235-57-9 | 99.2% | C3H7BO2 | 1 KG

Supplier: Medchemexpress LLC HY592191KG
Cyclopropylboronic acid is an intermediate used to synthesize EGFR kinase inhibitor (Compound 25). Compound 25 has antiproliferative effects on EGFR mutant (EGFR Δ19del/T790M/C797S) cells and can be used in lung cancer research.
- Intermediate used to synthesize EGFR kinase inhibitor (Compound 25)
- Exhibits antiproliferative effects on EGFR mutant (EGFR Δ19del/T790M/C797S) cells
- Applicable in lung cancer research
- Inhibits Ba/F3 triple-mutant suspension cells with an IC50 of 642 nM
- Appearance as an off-white to yellow solid
- Soluble in DMSO at concentrations of 100 mg/mL or greater
- Powder stable for 3 years at -20°C
- In solvent, stable for 6 months at -80°C or 1 month at -20°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.